Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Aliaga A., Kostikov A., Maclaren D. A., Clark S. D., Bedard M. A. (2014). PET imaging with [(1)(8)F]fluoroethoxybenzovesamicol ([(1)(8)F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat, Nucl Med Biol, 41(1), 96-101. Find out more.

Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Clark S. D., Aghourian M., Bedard M. A. (2014). Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [F]fluoroethoxybenzovesamicol, Behav Brain Res, 278C, 107-114. Find out more.

Gauthier S., Leuzy A., Rosa-Neto P. (2014). How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?, Neurodegener Dis, 13(2-3), 197-9. Find out more.

Kim D., Kim R. G., Kim H. S., Kim J. M., Jun S. C., Lee B., Jo H. J., Rosa-Neto P., Lee M. C., Kim H. I. (2014). Longitudinal changes in resting-state brain activity in a capsular infarct model, J Cereb Blood Flow Metab. Find out more.

Kim H. S., Kim D., Kim R. G., Kim J. M., Chung E., Rosa-Neto P., Lee M. C., Kim H. I. (2014). A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study, J Cereb Blood Flow Metab, 34(4), 683-9. Find out more.

Leuzy A., Zimmer E. R., Bhat V., Rosa-Neto P., Gauthier S. (2014). Imaging biomarkers for amyloid: a new generation of probes and what lies ahead, Int Psychogeriatr, 26(5), 703-7. Find out more.

Leuzy A., Zimmer E. R., Heurling K., Rosa-Neto P., Gauthier S. (2014). Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues, Amyloid, 21(3), 143-8. Find out more.

Milella M. S., Marengo L., Larcher K., Fotros A., Dagher A., Rosa-Neto P., Benkelfat C., Leyton M. (2014). Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study, NeuroImage, 98, 195-202. Find out more.

Ongali B., Nicolakakis N., Tong X. K., Aboulkassim T., Papadopoulos P., Rosa-Neto P., Lecrux C., Imboden H., Hamel E. (2014). Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model, Neurobiol Dis, 68, 126-36. Find out more.

Wu L., Soder R. B., Schoemaker D., Carbonnell F., Sziklas V., Rowley J., Mohades S., Fonov V., Bellec P., Dagher A., Shmuel A., Jia J., Gauthier S., Rosa-Neto P. (2014). Resting state executive control network adaptations in amnestic mild cognitive impairment, J Alzheimers Dis, 40(4), 993-1004. Find out more.

Zimmer E. R., Leuzy A., Benedet A. L., Breitner J., Gauthier S., Rosa-Neto P. (2014). Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging, J Neuroinflammation, 11, 120. Find out more.

Zimmer E. R., Leuzy A., Bhat V., Gauthier S., Rosa-Neto P. (2014). In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals, Transl Neurodegener, 3(1), 6. Find out more.

Zimmer E. R., Leuzy A., Gauthier S., Rosa-Neto P. (2014). Developments in Tau PET Imaging, Can J Neurol Sci, 41(5), 547-53. Find out more.

Zimmer E. R., Parent M. J., Cuello A. C., Gauthier S., Rosa-Neto P. (2014). MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research, Trends Neurosci. Find out more.